Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2025-06-12 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
关于使用自有闲置资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the progress of using its own idle funds to purchase financial products. It includes specifics about the amounts, types of financial products, expected yields, investment directions, and risk control measures. The document is a disclosure about the company's financing activities related to entrusted wealth management products, including approvals by the board and shareholders, and compliance with stock exchange rules. It is not a financial report like an annual or interim report, nor is it a regulatory certification or a voting result. It is an update on the company's capital usage and financing activities. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (7819 characters) and content confirm it is a substantive announcement, not just a brief notice or report publication announcement.
2025-06-12 Chinese
公司章程
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association for Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board structure, share issuance, capital changes, shareholder meetings, and governance rules. It is not a financial report, earnings release, or announcement but a governance document outlining internal rules and procedures. The presence of detailed chapters on board, shareholders, meetings, and governance practices aligns with the definition of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance charter, not a brief announcement or summary.
2025-05-27 Chinese
关于拟减少注册资本通知债权人的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the proposed reduction of registered capital and notification to creditors. It details the board and shareholder meeting approvals, the reduction in share capital due to repurchase and cancellation of restricted shares, and instructions for creditors to submit claims within 45 days. The document is a formal notice to creditors about capital reduction and related procedures, not a financial report or detailed management discussion. It does not contain financial statements or detailed financial data. It is an official announcement related to capital structure changes and creditor notification, fitting the category of Capital/Financing Update (CAP). The document length is short and focused on capital reduction and creditor notification, not a full report or regulatory filing. Therefore, the best classification is CAP with high confidence.
2025-05-27 Chinese
上海天璇律师事务所关于四川梓橦宫药业股份有限公司2024年年度股东会的法律意见书
Regulatory Filings
2025-05-27 Chinese
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 Annual General Meeting (AGM) of Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes information about the meeting date, attendance, voting results on various agenda items including the annual report, audit report, financial statements, dividend plan, and other corporate matters. The document also contains legal opinions confirming the validity of the meeting and voting process. The content is focused on the official voting results and decisions made at the AGM rather than the full annual report or financial statements themselves. The document length is under 5,000 characters and it primarily serves as an official announcement of the AGM voting results. Therefore, it fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-27 Chinese
平安证券股份有限公司关于四川梓橦宫药业股份有限公司2024年度持续督导跟踪报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2024年度持续督导跟踪报告" (2024 Annual Continuous Supervision Follow-up Report) issued by the sponsoring institution Ping An Securities Co., Ltd. for Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the ongoing supervision activities, including review of company disclosures, governance, fundraising use, and compliance with commitments. The document is a detailed report on the sponsor's continuous supervision work rather than a full annual report or audit report. It is not an announcement or a brief notice but a substantive report on regulatory compliance and supervision. This type of document aligns with the category of Audit Report / Information (AR), which includes standalone audit or supervision reports and related regulatory compliance information, excluding full annual reports. The document length is 3209 characters, which is substantive but not a full annual report. Therefore, the best classification is AR with high confidence. FY 2024
2025-05-18 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.